Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTEMTempus AI$64.78-6.0%$49.30$22.89▼$91.45$11.16BN/A6.14 million shs15.38 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTEMTempus AI-5.99%+10.25%+50.20%-22.65%+6,477,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationTEMTempus AI1.6677 of 5 stars2.32.00.00.03.32.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceTEMTempus AI 2.54Moderate Buy$61.50-5.06% DownsideCurrent Analyst Ratings BreakdownLatest FSG, TEM, BHMG, and RAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $65.005/7/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $70.004/24/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $70.004/21/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$60.004/10/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$70.00 ➝ $70.003/6/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $60.003/4/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$70.00 ➝ $55.003/3/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$54.00 ➝ $60.002/26/2025TEMTempus AIWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold2/25/2025TEMTempus AIWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookTEMTempus AI$803.32M13.89N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateTEMTempus AI-$289.81M-$7.80N/AN/AN/AN/AN/A-111.38%N/ALatest FSG, TEM, BHMG, and RAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025TEMTempus AI-$0.27-$0.24+$0.03-$0.40$248.13 million$255.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthTEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioTEMTempus AI8.172.692.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipTEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipTEMTempus AI27.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableTEMTempus AI2,300172.21 millionN/AN/AFSG, TEM, BHMG, and RAT HeadlinesRecent News About These CompaniesTempus AI, Inc. (NASDAQ:TEM) Position Increased by Captrust Financial AdvisorsMay 15 at 4:14 AM | marketbeat.comTempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer PipelineMay 14 at 12:15 PM | tmcnet.comArtificial Intelligence (AI) in Clinical Trials Market Insights, Competitive Landscape, and Forecasts Report 2025-2032 Featuring Key Players Such as TEMPUS, NetraMark, ConcertAI, AiCure, and OracleMay 14 at 7:36 AM | globenewswire.comWhy Tempus AI Inc. (TEM) Skyrocketed On TuesdayMay 14 at 2:13 AM | msn.comTempus Announces Six Posters Accepted for Presentation at ISPOR 2025May 13 at 4:05 PM | businesswire.comBig Earnings Beats: 6 Stocks That Spiked After Reporting ResultsMay 13 at 12:21 PM | 247wallst.comIs Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now?May 13 at 12:09 PM | insidermonkey.comBiovica Collaborates with Tempus to Expand the Commercial Reach of DiviTum(R) TKaMay 13 at 2:52 AM | finance.yahoo.com20,000 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Crestline Management LPMay 12 at 5:09 AM | marketbeat.comTudor Investment Corp ET AL Invests $348,000 in Tempus AI, Inc. (NASDAQ:TEM)May 12 at 3:45 AM | marketbeat.comMorgan Stanley Boosts Tempus AI (NASDAQ:TEM) Price Target to $65.00May 12 at 1:44 AM | americanbankingnews.comTempus AI, Inc. (NASDAQ:TEM) Shares Bought by Frontier Capital Management Co. LLCMay 11, 2025 | marketbeat.comCircle Wealth Management LLC Makes New Investment in Tempus AI, Inc. (NASDAQ:TEM)May 11, 2025 | marketbeat.comBrevan Howard Capital Management LP Takes $682,000 Position in Tempus AI, Inc. (NASDAQ:TEM)May 11, 2025 | marketbeat.comJim Cramer Says Stay Away from This Nancy Pelosi StockMay 10, 2025 | insidermonkey.comMarketBeat Week in Review – 05/05 - 05/09 (TEM)May 10, 2025 | marketbeat.comBenjamin Edwards Inc. Acquires 23,173 Shares of Tempus AI, Inc. (NASDAQ:TEM)May 10, 2025 | marketbeat.comTempus AI, Inc. (NASDAQ:TEM) Shares Acquired by Stifel Financial CorpMay 10, 2025 | marketbeat.comBest Artificial Intelligence Stocks To Keep An Eye On - May 8thMay 10, 2025 | americanbankingnews.comThese AI Stocks Posted Robust Results: Time to Buy?May 9, 2025 | zacks.comTempus AI (NASDAQ:TEM) Sees Strong Trading Volume Following Strong EarningsMay 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesTempus AI Stock: Time to Double Down or Cut and Run?By Thomas Hughes | May 8, 2025View Tempus AI Stock: Time to Double Down or Cut and Run?Could Palantir’s Latest Partnership Set a Base for a Move Higher?By Chris Markoch | April 23, 2025View Could Palantir’s Latest Partnership Set a Base for a Move Higher?3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest LoserBy Leo Miller | May 13, 2025View 3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest LoserViking Therapeutics Stock May Struggle After As-Expected ReportBy Chris Markoch | April 25, 2025View Viking Therapeutics Stock May Struggle After As-Expected ReportIf You Wanted To Buy AbbVie and Didn’t, There’s Still Time To BuyBy Thomas Hughes | April 25, 2025View If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To BuyFSG, TEM, BHMG, and RAT Company DescriptionsTempus AI NASDAQ:TEM$64.78 -4.13 (-5.99%) As of 05/14/2025 04:00 PM EasternTempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
